Average Co-Inventor Count = 7.79
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (15 from 1,970 patents)
2. University of Texas System (7 from 5,444 patents)
3. Chempartner Corporation (7 from 7 patents)
4. Cytokinetics, Inc. (4 from 257 patents)
5. Amgen Sf, LLC (4 from 5 patents)
6. Tularik Limited (1 from 126 patents)
7. Vincere Biosciences, Inc. (1 from 1 patent)
28 patents:
1. 12091425 - Compounds that inhibit MCL-1 protein
2. 11845724 - USP30 inhibitors and uses thereof
3. 11780826 - Bisamide sarcomere activating compounds and uses thereof
4. 11434233 - Heterocyclic inhibitors of ATR kinase
5. 11306107 - Compounds that inhibit MCL-1 protein
6. 11299479 - Bisamide sarcomere activating compounds and uses thereof
7. 10899746 - Bisamide sarcomere activating compounds and uses thereof
8. 10894052 - Heterocyclic inhibitors of ATR kinase
9. 10800774 - Heterocyclic inhibitors of ATR kinase
10. 10800769 - Heterocyclic inhibitors of ATR kinase
11. 10745420 - Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase
12. 10723720 - Bisamide sarcomere activating compounds and uses therof
13. 10421765 - Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase
14. 10392376 - Heterocyclic inhibitors of ATR kinase
15. 9873704 - Heterocyclic compounds and their uses